Your browser doesn't support javascript.
loading
Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma.
Datta, Debanjali; Dasgupta, Archya; Chatterjee, Abhishek; Sahu, Arpita; Bhattacharya, Kajari; Meena, Lilawati; Joshi, Kishore; Puranik, Ameya; Dev, Indraja; Moiyadi, Aliasgar; Shetty, Prakash; Singh, Vikas; Patil, Vijay; Menon, Nandini; Sridhar, Epari; Sahay, Ayushi; Gupta, Tejpal.
Afiliación
  • Datta D; Department of Radiation Oncology, Tata Memorial Centre, Mumbai 400012, India.
  • Dasgupta A; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Chatterjee A; Department of Radiation Oncology, Tata Memorial Centre, Mumbai 400012, India.
  • Sahu A; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Bhattacharya K; Department of Radiation Oncology, Tata Memorial Centre, Mumbai 400012, India.
  • Meena L; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Joshi K; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Puranik A; Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai 400012, India.
  • Dev I; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Moiyadi A; Department of Radio-Diagnosis, Tata Memorial Centre, Mumbai 400012, India.
  • Shetty P; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Singh V; Department of Medical Physics, Tata Memorial Centre, Mumbai 400012, India.
  • Patil V; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Menon N; Department of Medical Physics, Tata Memorial Centre, Mumbai 400012, India.
  • Sridhar E; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
  • Sahay A; Department of Nuclear Medicine, Tata Memorial Centre, Mumbai 400012, India.
  • Gupta T; Homi Bhabha National Institute (HBNI), Mumbai 400012, India.
J Pers Med ; 13(4)2023 Apr 19.
Article en En | MEDLINE | ID: mdl-37109071
BACKGROUND: Re-irradiation (ReRT) is an effective treatment modality in appropriately selected patients with recurrent/progressive high-grade glioma (HGG). The literature is limited regarding recurrence patterns following ReRT, which was investigated in the current study. METHODS: Patients with available radiation (RT) contours, dosimetry, and imaging-based evidence of recurrence were included in the retrospective study. All patients were treated with fractionated focal conformal RT. Recurrence was detected on imaging with magnetic resonance imaging (MRI) and/ or amino-acid positron emission tomography (PET), which was co-registered with the RT planning dataset. Failure patterns were classified as central, marginal, and distant if >80%, 20-80%, or <20% of the recurrence volumes were within 95% isodose lines, respectively. RESULTS: Thirty-seven patients were included in the current analysis. A total of 92% of patients had undergone surgery before ReRT, and 84% received chemotherapy. The median time to recurrence was 9 months. Central, marginal, and distant failures were seen in 27 (73%), 4 (11%), and 6 (16%) patients, respectively. None of the patient-, disease-, or treatment-related factors were significantly different across different recurrence patterns. CONCLUSION: Failures are seen predominantly within the high-dose region following ReRT in recurrent/ progressive HGG.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: J Pers Med Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: J Pers Med Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza